Andreas Strüngmann (born 1950) is a German businessman and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion, making its subsidiary Sandoz the largest generic-drug company in the world. He currently has residences in Tegernsee and South Africa and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.
Attributes | Values |
---|---|
rdf:type |
|
rdfs:label |
|
rdfs:comment |
|
foaf:name |
|
name |
|
dcterms:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage | |
Link from a Wikipage to an external page | |
sameAs | |
dbp:wikiPageUsesTemplate | |
education | |
known for |
|
occupation |
|
has abstract |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
birth year |
|
education | |
occupation | |
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is Wikipage redirect of | |
is foaf:primaryTopic of |